SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-18-017451
Filing Date
2018-01-23
Accepted
2018-01-23 16:34:13
Documents
2

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROSPECTUS SUPPLEMENT d452256d424b5.htm 424B5 328065
2 GRAPHIC g452256g19j35.jpg GRAPHIC 38705
  Complete submission text file 0001193125-18-017451.txt   382447
Mailing Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709
Business Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709 919-313-9650
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-213643 | Film No.: 18542732
SIC: 2836 Biological Products, (No Diagnostic Substances)